Join the Hysingla ER group to help and get support from people like you.
Hysingla ER News
FDA Requiring Stronger Safety Labels for Opioid Medications
MONDAY, Aug. 4, 2025 – The U.S. Food and Drug Administration announced it will now be requiring updated safety labels for all opioid pain medications to better highlight the risks of long-term use,...
FDA Medwatch Alert: FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
July 31, 2025 – The U.S. Food and Drug Administration is requiring safety labeling changes to all opioid pain medications to better emphasize and explain the risks associated with their long-term...
Fewer Opioids Being Prescribed for Low Back Pain in the Emergency Department
FRIDAY, July 18, 2025 – From 2016 to 2022, 5.3 percent of all U.S. emergency department visits were related to low back pain, with opioid administration and prescription decreasing during this same...
Non-Opioids Can Ease Post-Dental Surgery Pain Better Than Opioids, Study Shows
THURSDAY, Jan. 9, 2025 – Over-the-counter (OTC) drugs acetaminophen and ibuprofen are better at managing dental pain than opioids. People who had their wisdom teeth removed got better results from...
FDA Medwatch Alert: Drug Safety Communication: All Opioid Pain Medicines - FDA Updates Prescribing Information to Provide Additional Guidance for Safe Use
ISSUE: The FDA is requiring several updates to the prescribing information for both immediate-release (IR) and extended release/long acting (ER/LA) opioid pain medicines. This includes stating for a...
FDA Medwatch Alert: Opioid Pain or Cough Medicines Combined With Benzodiazepines: Drug Safety Communication - FDA Requiring New Boxed Warnings About Serious Risks and Death
ISSUE: FDA review has found that the growing combined use of opioid medicines with benzodiazepines or other drugs that depress the central nervous system (CNS) has resulted in serious side effects,...
FDA Medwatch Alert: Opioid Pain Medicines: Drug Safety Communication - New Safety Warnings Added to Prescription Opioid Medications
ISSUE: FDA is warning about several safety issues with the entire class of opioid pain medicines. See the FDA Drug Safety Communication for a complete listing. These safety risks are potentially h...